Related Experiment Video
Updated: Jun 12, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Treating comorbid substance use disorders in schizophrenia.
Dan I Lubman1, Joel A King, David J Castle
1Orygen Youth Health Research Centre, University of Melbourne, Melbourne, Australia.
International Review of Psychiatry (Abingdon, England)
|May 28, 2010
Summary
Treatments for schizophrenia with co-occurring substance use disorders (SUD) are limited. Integrated pharmacological and psychosocial interventions show promise, but more research is needed for evidence-based practice.
Area of Science:
- Psychiatry
- Addiction Medicine
- Clinical Psychology
Background:
- Schizophrenia frequently co-occurs with substance use disorders (SUD).
- Limited high-quality research exists for treating this dual diagnosis.
- Current literature primarily consists of case studies and observational data.
Purpose of the Study:
- To review existing pharmacological and psychosocial treatment strategies for individuals with schizophrenia and comorbid SUD.
- To identify evidence gaps and areas for future research.
Main Methods:
- Selective literature review of pharmacological and psychosocial interventions.
- Analysis of available randomized controlled trials, case studies, and other study designs.
Main Results:
- Clozapine and naltrexone show some efficacy for specific conditions.
- Integrated treatment approaches are generally considered most appropriate.
- Motivational interviewing, cognitive behavioral therapy, contingency management, and family interventions have emerging supportive literature.
- A flexible, individualized approach is necessary, as no single treatment fits all patients.
Conclusions:
- Integrated interventions combining pharmacological and psychosocial elements show potential benefits for schizophrenia with comorbid SUD.
- A significant gap exists in the literature, hindering the development of evidence-based practices.
- Further research is crucial to refine treatment strategies and identify patient subgroups who benefit most from specific interventions.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:24Substance Use Disorders Affecting Sleep
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...